Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Not applicableStudy completedNCT07566299
What this trial is testing

Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Obesity Type 2 Diabetes MellitusCardiovascular-kidney-metabolic SyndromeMetabolic Dysfunction-Associated Steatotic Liver Disease
Chung Shan Medical University 118,805
Post-approval studies (Phase 4)Looking for participantsNCT06774079
What this trial is testing

Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients

Who this might be right for
Crohn Disease
University of Miami 24
Not applicableWithdrawnNCT06982378
What this trial is testing

GLP-1 RA on Liver OMICS in MASLD

Who this might be right for
NAFLDDiabetesObesity
Medical College of Wisconsin
Testing effectiveness (Phase 2)Active Not RecruitingNCT04019197
What this trial is testing

Effects of Semaglutide in HIV-Associated Lipohypertrophy

Who this might be right for
HIV/AIDSLipohypertrophyObesity
Case Western Reserve University 108
Not applicableLooking for participantsNCT07760896
What this trial is testing

The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness

Who this might be right for
Wellness
Saundra Jain 200
Post-approval studies (Phase 4)Study completedNCT01455441
What this trial is testing

The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Tina Vilsboll 40
Not applicableLooking for participantsNCT06654219
What this trial is testing

Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 136
Testing effectiveness (Phase 2)Looking for participantsNCT05822609
What this trial is testing

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Who this might be right for
Diabetic Kidney DiseaseType 1 Diabetes
University of Washington 60
Large-scale testing (Phase 3)Looking for participantsNCT07736911
What this trial is testing

Discontinuation One Week Recommendations for GLP-1 Receptor Agonists Prior to Esophagogastroduodenoscopy.

Who this might be right for
GLP-1
Fu Jen Catholic University Hospital 140
Not applicableNot Yet RecruitingNCT07817823
What this trial is testing

Yeast Protein Supplementation and Muscle Preservation During GLP-1RA-Induced Weight Loss

Who this might be right for
Overweight and Obesity in Adults Receiving GLP-1RA Treatment
Huazhong University of Science and Technology 200
Not applicableLooking for participantsNCT07393360
What this trial is testing

Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment

Who this might be right for
Obesity & Overweight
Pharmanutra S.p.a. 144
Not applicableEnded earlyNCT07190794
What this trial is testing

RESCUE: Discontinuation of GLP-1

Who this might be right for
Obesity
Boston Scientific Corporation 18
Testing effectiveness (Phase 2)Looking for participantsNCT06976619
What this trial is testing

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Mayo Clinic 60
Testing effectiveness (Phase 2)Study completedNCT07370922
What this trial is testing

Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

Who this might be right for
Transfusion Dependent Beta Thalassemia
Ain Shams University 80
Not applicableStudy completedNCT06154486
What this trial is testing

Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study

Who this might be right for
Pneumonia, AspirationAnesthesia
Hospital Israelita Albert Einstein 30
Not applicableLooking for participantsNCT06069622
What this trial is testing

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Who this might be right for
Overweight and Obesity
Brigham and Women's Hospital 30
Post-approval studies (Phase 4)Not Yet RecruitingNCT07073053
What this trial is testing

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

Who this might be right for
Glucagon-Like Peptide-1 Receptor AgonistsType 2 DiabetesCoronary Arterial Disease (CAD)
Taipei Veterans General Hospital, Taiwan 60
Post-approval studies (Phase 4)Active Not RecruitingNCT04892199
What this trial is testing

Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?

Who this might be right for
Metabolic DisturbanceSchizophreniaType 2 Diabetes+3 more
Anders Fink-Jensen, MD, DMSci 104